Climb Bio, Inc.（CLYM）内部人交易：高管与董事近期交易
过去 18 个月，共有 10 位内部人为 Climb Bio, Inc.（CLYM）报告了 69 笔 Form 4 交易（最近一笔 2026-09-30）。
| 日期 | 内部人 | 职务 | 类型 | 股数 | 市值 |
|---|---|---|---|---|---|
| 2026-09-30 | RA Capital Healthcare Fund LP | 董事 | 买入 | 10,000 | $34,600 |
| 2026-09-30 | RA Capital Nexus Fund II, L.P. | 董事 | 买入 | 10,000 | $78,900 |
| 2026-09-30 | Kolchinsky Peter | 董事 | 买入 | 10,000 | $34,600 |
| 2026-09-30 | Shah Rajeev M. | 董事 | 买入 | 10,000 | $34,600 |
| 2026-09-30 | RA Capital Nexus Fund, L.P. | 董事 | 买入 | 10,000 | $34,600 |
| 2026-09-30 | RA Capital Nexus Fund II, L.P. | 董事 | 买入 | 10,000 | $34,600 |
| 2026-09-30 | RA Capital Nexus Fund III, L.P. | 董事 | 买入 | 10,000 | $34,600 |
| 2026-09-30 | RA CAPITAL MANAGEMENT, L.P. | 董事 | 买入 | 10,000 | $34,600 |
| 2026-09-30 | RA CAPITAL MANAGEMENT, L.P. | 董事 | 买入 | 10,000 | $30,000 |
| 2026-09-30 | Kolchinsky Peter | 董事 | 买入 | 10,000 | $30,000 |
| 2026-09-30 | Shah Rajeev M. | 董事 | 买入 | 10,000 | $30,000 |
| 2026-09-30 | RA Capital Nexus Fund, L.P. | 董事 | 买入 | 10,000 | $30,000 |
| 2026-09-30 | RA Capital Nexus Fund II, L.P. | 董事 | 买入 | 10,000 | $30,000 |
| 2026-09-30 | RA Capital Nexus Fund III, L.P. | 董事 | 买入 | 10,000 | $30,000 |
| 2026-09-30 | RA Capital Healthcare Fund LP | 董事 | 买入 | 10,000 | $78,900 |
| 2026-09-30 | RA CAPITAL MANAGEMENT, L.P. | 董事 | 买入 | 10,000 | $78,900 |
| 2026-09-30 | Kolchinsky Peter | 董事 | 买入 | 10,000 | $78,900 |
| 2026-09-30 | Shah Rajeev M. | 董事 | 买入 | 10,000 | $78,900 |
| 2026-09-30 | RA Capital Nexus Fund, L.P. | 董事 | 买入 | 10,000 | $78,900 |
| 2026-09-30 | Shah Rajeev M. | 董事 | 买入 | 40,000 | $51,600 |
| 2026-09-30 | RA Capital Nexus Fund III, L.P. | 董事 | 买入 | 10,000 | $78,900 |
| 2026-09-30 | RA Capital Healthcare Fund LP | 董事 | 买入 | 40,000 | $51,600 |
| 2026-09-30 | RA CAPITAL MANAGEMENT, L.P. | 董事 | 买入 | 40,000 | $51,600 |
| 2026-09-30 | Kolchinsky Peter | 董事 | 买入 | 40,000 | $51,600 |
| 2026-09-30 | RA Capital Healthcare Fund LP | 董事 | 买入 | 10,000 | $30,000 |
来源：SEC Form 4 申报文件 · 截至 2026-09-30